Braden Michael Leonard's Net Worth
Braden Michael Leonard's net worth is estimated to be at least $42,262,455.14 as of 04/01/2025. CoreStreet's estimation of Braden Michael Leonard's net worth is based on their sale of stock and current holding of stock.
Braden Michael Leonard is Major Shareholder at Adverum Biotechnologies Inc. They have executed at least 81 trades of stock as per SEC Form 4 filings. Their most recent trade was for 20,407 units of ADVM stock on 03/26/2025. Their biggest sale was on 01/04/2023 when they sold 1,250,000 units of Imara Inc stock for $5,000,000.00. They typically trade 11 times per year.
Total value of insider buys:
- $14,509,697.96
Total value of insider sells:
- $27,752,757.18
Most recent insider trade:
- March 26, 2025
Braden Michael Leonard's Insider Trading History
| Adverum Biotechnologies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 26, 2025 | Major Shareholder | 20,407 | $5.04 | Buy | $102,851.28 |
March 20, 2025 | Major Shareholder | 30,600 | $5.61 | Buy | $171,666.00 |
March 18, 2025 | Major Shareholder | 62,341 | $4.69 | Buy | $292,379.29 |
July 30, 2024 | Major Shareholder | 85,800 | $7.15 | Buy | $613,470.00 |
July 17, 2024 | Major Shareholder | 135,546 | $7.75 | Buy | $1,050,481.50 |
| Reneo Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 24, 2024 | Major Shareholder | 29,600 | $1.41 | Buy | $41,736.00 |
Sept. 17, 2024 | Major Shareholder | 55,300 | $1.36 | Buy | $75,208.00 |
Aug. 13, 2024 | Major Shareholder | 171,339 | $1.39 | Buy | $238,161.21 |
May 14, 2024 | Major Shareholder | 414,281 | $1.54 | Buy | $637,992.74 |
| Talis Biomedical Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 3, 2024 | Major Shareholder | 500 | $4.00 | Buy | $2,000.00 |
Aug. 30, 2024 | Major Shareholder | 151 | $4.25 | Buy | $641.75 |
Aug. 28, 2024 | Major Shareholder | 1,215 | $3.96 | Buy | $4,811.40 |
Aug. 26, 2024 | Major Shareholder | 13,167 | $3.90 | Buy | $51,351.30 |
| Aclaris Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 30, 2024 | Major Shareholder | 173,730 | $1.30 | Buy | $225,849.00 |
July 22, 2024 | Major Shareholder | 17,716 | $1.33 | Buy | $23,562.28 |
July 18, 2024 | Major Shareholder | 130,317 | $1.30 | Buy | $169,412.10 |
July 5, 2024 | Major Shareholder | 123,017 | $1.15 | Buy | $141,469.55 |
July 3, 2024 | Major Shareholder | 143,288 | $1.16 | Buy | $166,214.08 |
July 1, 2024 | Major Shareholder | 107,434 | $1.14 | Buy | $122,474.76 |
June 27, 2024 | Major Shareholder | 235,000 | $1.15 | Buy | $270,250.00 |
June 17, 2024 | Major Shareholder | 150,000 | $1.13 | Buy | $169,500.00 |
June 13, 2024 | Major Shareholder | 528,621 | $1.15 | Buy | $607,914.15 |
June 11, 2024 | Major Shareholder | 1,000,000 | $1.08 | Buy | $1,080,000.00 |
| AVROBIO Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 13, 2024 | Major Shareholder | 469,753 | $1.25 | Buy | $587,191.25 |
| Imara Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 4, 2023 | Major Shareholder | 1,250,000 | $4.00 | Sell | $5,000,000.00 |
Dec. 30, 2022 | Major Shareholder | 20,000 | $4.04 | Sell | $80,800.00 |
Dec. 28, 2022 | Major Shareholder | 157 | $4.04 | Sell | $634.28 |
Dec. 22, 2022 | Major Shareholder | 1,078 | $4.06 | Sell | $4,376.68 |
June 16, 2022 | Major Shareholder | 83,199 | $1.11 | Buy | $92,350.89 |
June 6, 2022 | Major Shareholder | 2,630 | $1.16 | Buy | $3,050.80 |
June 3, 2022 | Major Shareholder | 30,800 | $1.14 | Buy | $35,112.00 |
May 16, 2022 | Major Shareholder | 15,000 | $1.17 | Buy | $17,550.00 |
April 21, 2022 | Major Shareholder | 552,000 | $1.40 | Buy | $772,800.00 |
| Metacrine Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 21, 2022 | Major Shareholder | 120,099 | $0.40 | Buy | $48,039.60 |
Dec. 19, 2022 | Major Shareholder | 101,384 | $0.40 | Buy | $40,553.60 |
Nov. 9, 2022 | Major Shareholder | 39,816 | $0.39 | Buy | $15,528.24 |
Nov. 7, 2022 | Major Shareholder | 123,954 | $0.42 | Buy | $52,060.68 |
Oct. 28, 2022 | Major Shareholder | 45,022 | $0.40 | Buy | $18,008.80 |
Oct. 26, 2022 | Major Shareholder | 588,533 | $0.35 | Buy | $205,986.55 |
Oct. 24, 2022 | Major Shareholder | 174,354 | $0.34 | Buy | $59,280.36 |
| Astrotech Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 2, 2022 | Major Shareholder | 190,971 | $0.34 | Buy | $64,930.14 |
Nov. 23, 2022 | Major Shareholder | 75,000 | $0.33 | Buy | $24,750.00 |
Oct. 18, 2022 | Major Shareholder | 50,000 | $0.39 | Buy | $19,500.00 |
Oct. 14, 2022 | Major Shareholder | 166,434 | $0.38 | Buy | $63,244.92 |
Sept. 26, 2022 | Major Shareholder | 100,000 | $0.44 | Buy | $44,000.00 |
Sept. 23, 2022 | Major Shareholder | 100,000 | $0.43 | Buy | $43,000.00 |
Aug. 23, 2022 | Major Shareholder | 311,733 | $0.45 | Buy | $140,279.85 |
| Satsuma Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 21, 2022 | Major Shareholder | 150,000 | $0.71 | Buy | $106,500.00 |
Nov. 14, 2022 | Major Shareholder | 5,608,306 | $0.69 | Buy | $3,869,731.14 |
| Gemini Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 26, 2022 | Major Shareholder | 22,500 | $2.09 | Sell | $47,025.00 |
April 13, 2022 | Major Shareholder | 191,769 | $1.52 | Buy | $291,488.88 |
April 11, 2022 | Major Shareholder | 504,487 | $1.35 | Buy | $681,057.45 |
| ProPhase Labs Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2017 | Major Shareholder | 1,695,305 | $2.30 | Sell | $3,899,201.50 |
Nov. 7, 2014 | Major Shareholder | 64,746 | $1.34 | Buy | $86,759.64 |
Oct. 9, 2014 | Major Shareholder | 284,885 | $1.30 | Buy | $370,350.50 |
Oct. 8, 2014 | Major Shareholder | 114,910 | $1.30 | Buy | $149,383.00 |
Oct. 2, 2014 | Major Shareholder | 16,900 | $1.40 | Buy | $23,660.00 |
Sept. 24, 2014 | Major Shareholder | 48,596 | $1.40 | Buy | $68,034.40 |
Sept. 23, 2014 | Major Shareholder | 16 | $1.38 | Buy | $22.08 |
Sept. 22, 2014 | Major Shareholder | 44,042 | $1.40 | Buy | $61,658.80 |
Sept. 18, 2014 | Major Shareholder | 12,500 | $1.41 | Buy | $17,625.00 |
Sept. 15, 2014 | Major Shareholder | 121,940 | $1.45 | Buy | $176,813.00 |
| Build-A-Bear Workshop Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2017 | Director | 27,000 | $9.21 | Sell | $248,670.00 |
Sept. 26, 2017 | Director | 47,619 | $9.03 | Sell | $429,999.57 |
Sept. 20, 2017 | Director | 22,381 | $9.02 | Sell | $201,876.62 |
Sept. 18, 2017 | Director | 80,000 | $8.99 | Sell | $719,200.00 |
Aug. 17, 2015 | Director | 70,000 | $21.15 | Sell | $1,480,500.00 |
March 11, 2015 | Director | 12,000 | $20.62 | Sell | $247,440.00 |
Jan. 12, 2015 | Director | 120,000 | $20.23 | Sell | $2,427,600.00 |
Jan. 9, 2015 | Director | 108,200 | $19.41 | Sell | $2,100,162.00 |
Nov. 18, 2014 | Director | 20,000 | $18.96 | Sell | $379,200.00 |
Nov. 6, 2014 | Director | 31,500 | $18.43 | Sell | $580,545.00 |
Oct. 31, 2014 | Director | 15,000 | $17.14 | Sell | $257,100.00 |
Oct. 30, 2014 | Director | 180,000 | $17.06 | Sell | $3,070,800.00 |
Aug. 27, 2014 | Director | 75,583 | $13.51 | Sell | $1,021,126.33 |
May 30, 2014 | Director | 88,632 | $13.95 | Sell | $1,236,416.40 |
May 28, 2014 | Director | 61,368 | $14.39 | Sell | $883,085.52 |
May 21, 2014 | Director | 44,326 | $13.60 | Sell | $602,833.60 |
May 14, 2014 | Director | 30,674 | $13.82 | Sell | $423,914.68 |
May 12, 2014 | Director | 75,000 | $13.83 | Sell | $1,037,250.00 |
May 8, 2014 | Director | 100,000 | $13.73 | Sell | $1,373,000.00 |